Cayman Islands
|
001-40122
|
98-1574672
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
51 Astor Place, 10th Floor
New York, NY
|
10003
|
(Address of principal executive offices)
|
(Zip Code)
|
☒
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
Class A Ordinary Shares, par value $0.0001 per share
|
ARYD
|
The Nasdaq Capital Market
|
Exhibit No.
|
|
Description
|
|
Second Convertible Promissory Note, dated February 28, 2023 and issued to ARYA Sciences Holdings IV (incorporated by reference to Exhibit 10.1 of the 8-K filed on March 1, 2023 by the registrant).
|
|
|
Amendment to the Second Convertible Promissory Note, dated February 13, 2024, by and between ARYA Sciences Acquisition Corp IV and ARYA Sciences Holdings IV (incorporated by reference to Exhibit 10.14 of the
amendment to the Current Report on Form 8-K filed on February 14, 2024 by the registrant).
|
|
|
Fourth Convertible Promissory Note, dated February 8, 2024 and issued to ARYA Sciences Holdings IV (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on February 9, 2024 by the
registrant).
|
|
104
|
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
Dated: June 3, 2024
|
ARYA SCIENCES ACQUISITION CORP IV
|
|
|
|
|
|
By:
|
/s/ Michael Altman
|
|
Name:
|
Michael Altman
|
|
Title:
|
Chief Financial Officer
|